Dr. Mohammed Shabbir Ezzi

Introduction

Expertise

• Dr. Mohammed Ezzi is a seasoned medical oncologist with over 14 years of experience.
• His primary interest lies in the treatment and management of breast cancers, and his secondary interest lies in chronic myeloid leukaemia.
• He has handled over 3700 cases so far.

Training and Certifications

• Dr. Mohammed has completed his fellowship training in Medical Oncology at the University of Nairobi.

Recognition

• Dr. Mohammed Ezzi is a member of KESHO, ASCO, ESMO, AORTIC and KAP.
• He has several publications in peer-reviewed international journals.
• He has presented at several symposia, workshops and conferences both locally and internationally.
• Dr. Mohammed Ezzi serves as treasurer of the Kenya Society of Haematology and Oncology (KESHO).
• He is a member of the Multinational Association of Supportive Care in Cancer (MASCC), African Organisation of Research and Training in Cancer (AORTIC), European Society of Medical Oncology (ESMO), Member of Kenya Association of Physicians (KAP), Member of Kenya Society of Haematology and Oncology (KESHO) and many more. He is also a board member of the School of Medicine, University of Nairobi.

Publications

• Distribution of Salmonella Typhi Antibodies in the Sera of Healthy Blood Donors at Kenyatta National Hospital. Online J Med Med Sci Res, 2014; 3(3): 19-23.
• Insights into methotrexate in rheumatoid arthritis: a clinical review. Afr J Rheumatol 2016; 4(2): 42-46.
• Changes in Blood Pressure Levels and Antihypertensive Medication Use before and after Renal Transplantation among Patients in Nairobi, Kenya: A Comparative Cross-Sectional Study. International Journal of Hypertension, vol. 2016, Article ID 8450596, 5 pages, 2016.
• Knowledge, attitudes, and practice survey about antimicrobial resistance and prescribing among physicians in a hospital setting in Nairobi, Kenya. AJRM 2017: 12(2): 3-7.   
• Prevalence and Predictors of Cisplatin-Induced Peripheral Neuropathy at the Kenyatta National Hospital. J Glob Oncol. 2019 Sep; 5(5):1–6.  
• Cytopenia among CML Patients on Imatinib in Kenya: Types, Grades, and Time Course. Vesole DH, editor. Adv Hematol. 2020 May 12; 2020: 7696204.   
• Factors other than sheer numbers of blood cells in circulation may be responsible for clinical presentations in chronic myeloid leukaemia. J Clin Oncol. 2020 May 20; 38.

Other Doctors